Abstract:Salvianolic acid B (Sal B) is one of the main active ingredients of Salvia miltiorrhiza , with strong antioxidant effects. Recent findings have shown that Sal B has anti-inflammatory, anti-apoptotic, anti-fibrotic effects and can promote stem cell proliferation and differentiation, and has a beneficial effect on cardiovascular and cerebrovascular diseases, aging, and liver fibrosis. Reactive oxygen species (ROS) include oxygen free radicals and oxygen-containing non-free radicals. ROS can regulate cell proliferation, survival, death and differentiation to regulate inflammation, and immunity, while Sal B can scavenge oxygen free radicals by providing hydrogen atoms and reduce the production of oxygen free radicals and oxygen-containing non-radicals by regulating the expression of antioxidant enzymes. The many pharmacological effects of Sal B may be closely related to its elimination and inhibition of ROS generation, and Nuclear factor E2-related factor 2/Kelch-like ECH-related protein 1 may be the core link in its regulation of the expression of antioxidant enzyme to exert its antioxidant effect. What is confusing and interesting is that Sal B exhibits the opposite mechanisms in tumors. To clarify the specific target of Sal B and the correlation between its regulation of oxidative stress and energy metabolism homeostasis will help to further understand its role in different pathological conditions, and provide a scientific basis for its further clinical application and new drug development. Although Sal B has broad prospects in clinical application due to its extensive pharmacological effects, the low bioavailability is a serious obstacle to further improving its efficacy in vivo and promoting clinical application. Therefore, how to improve the availability of Sal B in vivo requires the joint efforts of many interdisciplinary subjects.

Current Progress of Research on Neurodegenerative Diseases of Salvianolic Acid B

Chinese Medicine-Derived Salvianolic Acid B for Disease Therapy: A Scientometric Study

Current progress of research on pharmacologic actions of salvianolic acid B

Pharmacological Effects of Salvianolic Acid B Against Oxidative Damage

Endoplasmic Reticulum Stress And Nf-Kappa B Pathway In Salidroside Mediated Neuroprotection: Potential Of Salidroside In Neurodegenerative Diseases

Salvianolic Acid B: A Review of Pharmacological Effects, Safety, Combination Therapy, New Dosage Forms, and Novel Drug Delivery Routes

Salvianolic Acid A, a Polyphenolic Derivative from Salvia Miltiorrhiza Bunge, As a Multifunctional Agent for the Treatment of Alzheimer's Disease.

The Effect of Salvianolic Acid on Vascular Protection and Possible Mechanisms

Pathway-pathway network-based study of the therapeutic mechanisms by which salvianolic acid B regulates cardiovascular diseases

Progress on the Role of Salidroside in Neurodegenerative Diseases

[Protective mechanism of salvianolic acid B on blood vessels].

Metabolomics Study on the Effects of Salvianolic Acid B and Borneol for Treating Cerebral Ischemia in Rats by Ultra-Performance Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry

Salvianolic Acid B Ameliorates Cognitive Deficits Through IGF-1/Akt Pathway in Rats with Vascular Dementia

Salvianolic acid B alleviates neurological injury by upregulating stanniocalcin 1 expression

Cardiovascular Effects of Salvianolic Acid B

Research progress on analytical method and preparation technology of salvianolic acids

Targeting post-stroke neuroinflammation with Salvianolic acid A: molecular mechanisms and preclinical evidence

Effects of Salvianolic Acid B on Survival, Self-Renewal and Neuronal Differentiation of Bone Marrow Derived Neural Stem Cells.

Salvianic Borneol Ester Reduces Β-Amyloid Oligomers and Prevents Cytotoxicity.

Salvianolic acid B from Salvia miltiorrhiza bunge: A potential antitumor agent

Salvianolic acid B inhibits Abeta fibril formation and disaggregates preformed fibrils and protects against Abeta-induced cytotoxicty